发明名称 |
TREATMENT OF MYELOMA BONE DISEASE WITH PROTEASOMAL AND NF- kappa B ACTIVITY INHIBITORS |
摘要 |
The present invention involves the identification and use of compositions for treating myeloma bone disease. The compositions inhibit proteasomal activity and decrease the activity of the transcription factor NF- kappa B. Assessment of a candidate compound for its ability to inhibit production or activity of proteasomal enzymes or NF- kappa B provides a useful means to identify agents to treat myeloma bone disease.
|
申请公布号 |
WO0061167(A2) |
申请公布日期 |
2000.10.19 |
申请号 |
WO2000US09121 |
申请日期 |
2000.04.07 |
申请人 |
OSTEOSCREEN, INC. |
发明人 |
MUNDY, GREGORY, R. |
分类号 |
G01N33/50;A61K31/165;A61K31/166;A61K31/167;A61K31/40;A61K31/435;A61K31/66;A61K38/00;A61K38/05;A61K38/06;A61K45/00;A61P19/08;A61P35/00;A61P43/00;C12Q1/37;G01N33/15;(IPC1-7):A61K38/04 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|